A detailed history of New York State Common Retirement Fund transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 16,346 shares of AVIR stock, worth $56,230. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,346
Previous 16,292 0.33%
Holding current value
$56,230
Previous $66,000 18.18%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$3.31 - $4.04 $178 - $218
54 Added 0.33%
16,346 $54,000
Q1 2024

May 07, 2024

SELL
$3.09 - $4.56 $163 - $241
-53 Reduced 0.32%
16,292 $66,000
Q4 2023

Feb 01, 2024

SELL
$2.8 - $3.35 $464 - $556
-166 Reduced 1.01%
16,345 $50,000
Q3 2023

Nov 07, 2023

BUY
$3.0 - $3.79 $621 - $784
207 Added 1.27%
16,511 $50,000
Q2 2023

Aug 07, 2023

SELL
$3.21 - $5.06 $234 - $369
-73 Reduced 0.45%
16,304 $61,000
Q1 2023

May 02, 2023

SELL
$3.0 - $4.97 $89,700 - $148,603
-29,900 Reduced 64.61%
16,377 $55,000
Q4 2022

Jan 30, 2023

SELL
$4.35 - $6.17 $56 - $80
-13 Reduced 0.03%
46,277 $223,000
Q3 2022

Nov 08, 2022

BUY
$5.49 - $8.79 $1,323 - $2,118
241 Added 0.52%
46,290 $263,000
Q2 2022

Aug 04, 2022

BUY
$5.33 - $8.18 $35,172 - $53,979
6,599 Added 16.73%
46,049 $327,000
Q1 2022

May 05, 2022

SELL
$5.5 - $9.19 $38,703 - $64,670
-7,037 Reduced 15.14%
39,450 $285,000
Q4 2021

Feb 02, 2022

SELL
$7.67 - $44.59 $1,441 - $8,382
-188 Reduced 0.4%
46,487 $416,000
Q3 2021

Nov 02, 2021

SELL
$21.33 - $35.06 $187,405 - $308,037
-8,786 Reduced 15.84%
46,675 $1.64 Million
Q2 2021

Aug 02, 2021

BUY
$19.22 - $59.08 $800,724 - $2.46 Million
41,661 Added 301.89%
55,461 $1.19 Million
Q1 2021

May 11, 2021

BUY
$41.42 - $88.44 $103,550 - $221,100
2,500 Added 22.12%
13,800 $852,000
Q4 2020

Feb 08, 2021

BUY
$26.36 - $41.78 $297,868 - $472,114
11,300 New
11,300 $472,000

Others Institutions Holding AVIR

About Atea Pharmaceuticals, Inc.


  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $286M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.